-
97
-
72
-
60
-
51
-
49
Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published:
2009-06-12
Proceedings
-
7th Meeting New Insight in Hematology
Published: June 12, 2009212PDF: 287
Articles
-
Molecular targeted therapies for indolent lymphomas: where are we?
Published: June 12, 2009185PDF: 201 -
The indolent extranodal lymphomas: What is the role of radiation therapy?
Published: June 12, 2009183PDF: 700 -
New treatment options for elderly myeloma patients: the Italian experience
Published: June 12, 2009197PDF: 265 -
The road to cure in multiple myeloma: incorporation of novel agents into autologous stem cell transplantation
Published: June 12, 2009194PDF: 122 -
The role of thalidomide as maintenance after autologous stem-cell transplantation in multiple myeloma
Published: June 12, 2009177PDF: 185 -
The role of maintenance treatment in myeloma
Published: June 12, 2009155PDF: 181 -
Have maintenance rituximab and RIC allograft blown away the need for autografts in follicular lymphoma?
Published: June 12, 2009181PDF: 123 -
Reduced-intensity conditioning for allograft after cytoreductive autograft in relapsed/ resistant Hodgkin’s lymphoma
Published: June 12, 2009220PDF: 136 -
Long-term results of reduced-intensity conditioning followed by allogeneic transplantation in relapsed lymphomas
Published: June 12, 2009289PDF: 172 -
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification?
Published: June 12, 2009213PDF: 330 -
High-dose CHOP in the rituximab era: still a place?
Published: June 12, 2009203PDF: 235 -
Radiotherapy in the rituximab era: still a place?
Published: June 12, 2009251PDF: 136 -
S.J. Horning Biomarkers in diffuse large B-cell lymphoma
Published: June 12, 2009174PDF: 348 -
High dose chemotherapy and autologous transplantation in anti-CD20 antibodies era: still a place?
Published: June 12, 2009167PDF: 233 -
Recent advances in the pathology of idiopathic thrombocytopenic purpura
Published: June 12, 2009211PDF: 771 -
Idiopathic thrombocytopenic purpura in adults: the treatment paradigm
Published: June 12, 2009170PDF: 548 -
Thrombopoietin receptor agonists in the treatment of chronic immune thrombocytopenic purpura
Published: June 12, 2009246PDF: 879 -
Are we getting closer to understanding the pathogenesis of chronic lymphocytic leukemia?
Published: June 12, 2009243PDF: 377 -
The continuing search for the cell of origin of chronic lymphocytic leukemia
Published: June 12, 2009167PDF: 616 -
Molecular cytogenetic lesions in chronic lymphocytic leukemia
Published: June 12, 2009200PDF: 816 -
What is gene profiling contributing to the characterization of chronic lymphocytic leukemia
Published: June 12, 2009152PDF: 130 -
The impact of diagnosis on the therapeutic management of chronic lymphocytic leukemia
Published: June 12, 2009191PDF: 220 -
How close are we to curing chronic lymphocytic leukemia?
Published: June 12, 2009164PDF: 220 -
Cyclophosphamide in chronic lymphocytic leukemia first line: final results of Chronic Lymphocytic Leukemia 8 Study
Published: June 12, 20095581PDF: 720 -
Lenalidomide: an emerging option in chronic lymphocytic leukemia
Published: June 12, 2009175PDF: 194 -
Ofatumumab: a second generation anti-CD20 monoclonal antibody in chronic lymphocytic leukemia
Published: June 12, 2009163PDF: 339 -
Hydroxyurea: the comparator in studies with new anti-JAK2 inhibitors
Published: June 12, 2009229PDF: 520 -
New biologic and therapeutic insights in Hodgkin’s lymphoma
Published: June 12, 2009180PDF: 206 -
Treatment approaches in early stage Hodgkin’s lymphoma
Published: June 12, 2009182PDF: 470 -
Advanced Hodgkin’s lymphoma: doxorubicin, bleomycin, vinblastine, dacarbazine and beyond
Published: June 12, 2009219PDF: 258 -
Treatment of refractory Hodgkin’s lymphoma: a puzzle to merge
Published: June 12, 2009143PDF: 267 -
Blastic plasmacytoid dendritic cell neoplasm
Published: June 12, 20094729PDF: 4046